Traws Pharma Stock

Traws Pharma EBITDA per Employee

The EBITDA per Employee of Traws Pharma (TRAW) as of Aug 13, 2026 is -1.56 M USD. In the previous year, EBITDA per Employee was -1.27 M USD — a change of 22.72% (lower).

EBITDA per Employee

-1.56 MUSD

YoY

22.72%

Last updated:

EBITDA per Employee of Traws Pharma is 2026 -1.56 M USD. EBITDA per Employee of Traws Pharma was 2025 -1.27 M USD. It decreases by 22.72% lower compared to the previous year.
Access this data via the Eulerpool API

Traws Pharma Stock analysis

What does Traws Pharma do? Traws Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Traws Pharma stock

EBITDA per Employee of Traws Pharma is -1.56 M USD in 2026.

EBITDA per Employee of Traws Pharma changed from -1.27 M USD to -1.56 M USD, representing a 22.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Traws Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Traws Pharma historically and in real time.

Access this data via the Eulerpool API

Workforce — Traws Pharma

All Key Metrics — Traws Pharma